CFO appointment
Sensei Biotherapeutics, Inc. appoints Brian Stephenson as CFO
Sensei Biotherapeutics, Inc. reported in a Form 8-K filed June 15, 2026 that Brian Stephenson was appointed Chief Financial Officer, effective June 13, 2026.
In the filing's words
Effective as of June 13, 2026, Brian Stephenson was appointed as the Company’s Chief Financial Officer and principal financial officer.
Verbatim from sec.gov, Item 5.02. We quote departures; we do not characterize them.
| Company | Sensei Biotherapeutics, Inc. (SNSE) |
|---|---|
| Event | Appointment |
| Incoming | Brian Stephenson |
| Title in the filing | Chief Financial Officer |
| Effective | June 13, 2026 |
| 8-K filed | June 15, 2026 |
| Internal promotion | Not established by the source |
| SEC CIK | 0001829802 |
Sensei Biotherapeutics, Inc. reported this change in a Form 8-K, Item 5.02, filed June 15, 2026. The filing's own words are quoted above.
Sources
- sec.gov · SEC filing, Item 5.02 · accessed 2026-09-26
Something wrong about Brian Stephenson? Send a correction with the primary source.